OpenAI is testing a new subscription model called “ChatGPT for Science,” aimed at scientific use cases. References to this feature surfaced on X, indicating its inclusion in OpenAI’s web build.
Currently, OpenAI offers various versions of ChatGPT, including personal, Teams, and business subscriptions. While the personal version is accessible to all users, the Teams version requires a company domain and a minimum of three users. The business variant is limited to legal entities.
OPENAI 🔥: A new ChatGPT plan for Science is being developed, according to the latest additions on the web build.
> OpenAI has been announcing various projects related to "Accelerating scientific progress" over the past year, including an open form for institutions to "Get… pic.twitter.com/o70FLu0nLL
— 🚨 AI News | TestingCatalog (@testingcatalog) June 17, 2026
ChatGPT for Science is expected to have similar access restrictions, likely limiting usage to verified institutes or universities. OpenAI has been optimizing its AI for scientific applications to enhance such offerings.
OpenAI previously introduced GPT-Rosalind, a model constructed on the GPT-5.5 architecture, tailored specifically for enterprise-scale life sciences research. This model is not simply a rebranded version of ChatGPT; it is designed for specialized scientific research.
Access to GPT-Rosalind operates under a “trusted-access deployment structure,” permitting usage only by eligible organizations. This includes major pharmaceutical companies and verified research institutions engaged in public-benefit scientific research. The model demands rigorous security and governance, akin to that of ChatGPT Enterprise.
ChatGPT for Science is expected to integrate similar capabilities but will focus on supporting scientific discoveries and research more than the standard subscriptions. Currently, no confirmed launch date exists for this model, but it is undergoing active testing. An announcement may be forthcoming in the upcoming weeks.
